PRL-3 Inhibitor I
SIGMA/P0108 - ≥98% (HPLC), solid
Synonym: 5-
CAS Number: 893449-38-2
Empirical Formula (Hill Notation): C17H11Br2NO2S2
Molecular Weight: 485.21
MDL Number: MFCD11045303
Linear Formula: C17H11Br2NO2S2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | yellow |
| form | solid |
| InChI | 1S/C17H11Br2NO2S2/c18-12- |
| InChI key | HXNBAOLVPAWYLT-OVCLIPMQSA |
| Quality Level | 100 ![]() |
| SMILES string | Brc1ccc(OCc2ccccc2Br)c(c1 |
| solubility | DMSO: >10 mg/mL |
| H2O: <2 mg/mL | |
| storage condition | protect from light |
| storage temp. | −20°C |
| Application: | PRL-3 Inhibitor I has been used as an inhibitor of phosphatase of regenerating liver-3 (PRL-3): • to test its effect on classical Hodgkin lymphoma cell survival • in the human umbilical vein endothelial cells tube formation assay • to test its effect on the migration of neural crest cells |
| Biochem/physiol Actions: | PRL-3 Inhibitor I is a rhodanine derivative with an IC50 value of 0.9 μM against phosphatase of regenerating liver-3 (PRL-3), a nonclassical protein tyrosine phosphatase that has recently been shown to be involved in cancer metastasis. PRL-3 Inhibitor I reduced the invasiveness of B16F10 melanoma cells in a cell based assay. |
| Features and Benefits: | This compound is featured on the Phosphoprotein Phosphatases (Tyrosine) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5 mg in glass bottle |
| Symbol | ![]() GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 - H410 |
| Precautionary statements | P261 - P273 - P305 + P351 + P338 - P501 |
| Hazard Codes | Xi,N |
| Risk Statements | 36/37/38-50/53 |
| Safety Statements | 26-36/37-60-61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |



